UNION KOREA PHARM Amends Share Listing Date for 60mn Share Third-Party Allotment, Delayed by One Week
UNION KOREA PHARM corrected the listing date of new shares in its previously announced paid-in capital increase from July 15, 2026 to July 22, 2026 due to practical delays with the securities depository.
The core terms of the 60 million share third-party allotment at a par value of 500 KRW per share remain unchanged, representing an 81.6% discount to the last trading price of 2,725 KRW.
Proceeds of 30 billion KRW will be used to repay rehabilitation claims, and the largest shareholder will change to Bukwang Pharmaceutical upon completion.
[AI Summary]This amendment is merely a procedural schedule adjustment with no material impact on shareholder value. However, the underlying massive dilution of over 75% for existing shareholders remains in effect, requiring investors to exercise caution.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)